Research participant's arm in a machine designed for motor impairment study

Motor Impairment

RESEARCH CENTRE

Motor Impairment is a major cause of physical disability and includes muscle weakness and fatigue, impaired sensation and poor balance, and muscle contracture and spasticity – all of which need to work if we are to undertake the usual range of daily activities.

The goals of our five-year (2014-2018), NHMRC-funded Motor Impairment Program are to better understand the pathophysiology of motor impairment, to implement interventions and to drive enhanced clinical practice.

 

LATEST NEWS AND EVENTS

Second International Motor Impairment Conference 2020 (Register Interest)

Following the success of the First International Motor Impairment Conference in Sydney, Australia in 2018, we are pleased to announce that the Second International Motor Impairment Conference will be held in Amsterdam on 17-19th November 2021.

 

The goal of these meetings is to better understand the pathophysiology of Motor Impairment, to implement interventions, and to drive enhanced clinical practice.  Much is still unknown about fundamental mechanisms of Motor Impairment, and about its prevention and treatment.

 

For news & updates

Register

your interest

today

 

 

Location: Hotel Casa, Amsterdam.

 

 

Bringing together the brightest minds working on Motor Impairment from all over the world.

 

First International Motor Impairment Conference 2018

Professor Simon Gandevia, Deputy Director at NeuRA announced that NeuRA will host the first International Motor Impairment Conference in Sydney Australia. Nov 26th-28th.

See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

‘Progressive. Incurable. Terminal. Nothing matters… I am going to die.’

‘There are days that I just cry like a baby. I’m meant to be the provider, the strong one. No son should have to change the underwear of their 57 year old father.’ Shin Liu is a man you want to know... kind, articulate and with love in his heart. At 57 years old however, Shin has planned his funeral. Two years ago, Shin was diagnosed with motor neurone disease (MND). Unlike many cancers or heart disease, there is not a single thing the medical profession can do to stop MND. This excruciating disease twists and contorts the human body in the most horrific way, and it quickly destroys the ability to move, speak, swallow and breathe. Life expectancy post diagnosis is 2.5 years. But NeuRA researchers are making exciting progress toward it's defeat. After years of meticulous research, we've learnt that in more than 90% of MND cases a protein called TDP-43 is responsible for the changes in motor neurones. In pre-clinical (non-human) trials, we have found that this protein can be controlled by a specially engineered peptide sequence (i.e. medication) which has the potential to stop MND in its tracks. But here is the most exciting development… we are observing improvements in movement, behaviour and memory upon administering this medication! This is innovative, ground-breaking research and we need your help to accelerate this research, which will in time enable clinical trials in people living with MND. Will you support or research today?
APPEAL

MyCOACH: Connected Advice for Cognitive Health

Researchers at Neuroscience Research Australia (NeuRA) and University of New South Wales (UNSW) are inviting people with Mild Cognitive Impairment (MCI) or Subjective Cognitive Decline (SCD) to participate in a voluntary online research trial aiming to reduce the risk of dementia. What is the MyCOACH Trial about? This research aims to test the effectiveness of an e-learning and behaviour change course designed to support healthy brain ageing and reduce risk of dementia.  The course is tailored for people reporting cognitive difficulties or changes. The trial runs for 12 weeks, with a follow up at 1 and 2 years afterwards. What is involved in this research trial? Interested volunteers will be asked to complete some eligibility checks to confirm this study is a good match.    If you decide to take part you would: Be placed into either the MyCOACH e-learning group (“Intervention”) or the Control Education group (“Control”). To ensure the research is fair and unbiased, we cannot choose the group for you.   It will be random - like names out of a hat. MyCOACH e-learning group (“Intervention”):  Volunteers in this group participate in the 12 week online MyCOACH program.  This includes 6 e-learning chapters, as well as three phone consultations with a dietician and/or exercise physiologist, and a 3-month subscription to a brain training app. Control Education group (“Control”): Volunteers in this group will receive information about cognitive health and risk factors for dementia.  This group is important to be able to measure the effectiveness of the research.  At the end of the study, volunteers in this “control” group can access the full MyCOACH e-learning course. Take part in four telephone interviews throughout the study with questions about your health. This includes a follow-up at the end of 12 weeks, and 1 and 2 years later. You may be eligible to participate in the MyCOACH Trial if you: Have concerns about changes in your memory or thinking OR diagnosed with ‘Mild Cognitive Impairment’ Are 65 years of age or older   Expressions of interest [ninja_forms id=376]   Contact If you are interested or know someone who might be, please contact us for more information: Dinaz Parekh Email: mycoach@neura.edu.au Phone: (02) 9399 1815
PROJECT